OXIS DEFINITIVE PROXY STATEMENT

Company

GT Biopharma, Inc.

Filed

July 14, 2011

Period of Report

July 13, 2011

Accession Number

0001513160-11-000047

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →